Catalyst Wire Dossier Catalyst Wire Dossier

Equisetum arvense extract

Equisetum arvense
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Equisetum arvense extract, covering 2025-08-07 to 2025-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Combination of Equisetum Arvense and Palmitoylethanolamide (PEA) for the Management of Patients With Chronic Pain in a Before-after Study [Phase 1, Phase 2]

See pricing